Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Deeptashree Nandi

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Frontiers in Immunology|November 18, 2024
Integrating immunotherapy with conventional treatment regime for breast cancer patients- an amalgamation of armamentariumDeeptashree Nandi, Dipali Sharma
Seminars in Cancer Biology|August 3, 2020
The pint- sized powerhouse: Illuminating the mighty role of the gut microbiome in improving the outcome of anti- cancer therapyIndranil Chattopadhyay, Deeptashree Nandi, Alo Nag
Gut Microbes|June 12, 2023
The gut microbiota in breast cancer development and treatment: The good, the bad, and the useful!Deeptashree Nandi, Sheetal Parida, Dipali Sharma
Cancer Metastasis Reviews|December 7, 2024
TRIM-endous functional network of tripartite motif 29 (TRIM29) in cancer progression and beyondQitong Wu, Deeptashree Nandi, Dipali Sharma
Open Biology|June 8, 2021
Exploring the therapeutic potential of forkhead box O for outfoxing COVID-19Pradeep Singh Cheema, Deeptashree Nandi, Alo Nag
Seminars in Cancer Biology|July 28, 2020
Significance of human microbiome in breast cancer: Tale of an invisible and an invincibleJatin Chadha, Deeptashree Nandi, Yama Atri, et al.
Seminars in Cancer Biology|September 1, 2017
FoxM1: Repurposing an oncogene as a biomarkerDeeptashree Nandi, Pradeep Singh Cheema, Neha Jaiswal, et al.
Carcinogenesis|June 23, 2022
The anaphase-promoting complex/cyclosome co-activator, Cdh1, is a novel target of human papillomavirus 16 E7 oncoprotein in cervical oncogenesisNeha Jaiswal, Deeptashree Nandi, Pradeep Singh Cheema, et al.
Breast Cancer Research : BCR|September 27, 2025
An enteropathogenic microbial toxin modulates the breast cancer epigenome resulting in concurrent silencing of tumor suppressor genesDeepak Verma, Deeptashree Nandi, Sheetal Parida, et al.
Frontiers in Oncology|December 13, 2021
Artemisinin Mediates Its Tumor-Suppressive Activity in Hepatocellular Carcinoma Through Targeted Inhibition of FoxM1Deeptashree Nandi, Pradeep Singh Cheema, Aakriti Singal, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Frontiers in Immunology|November 18, 2024
Integrating immunotherapy with conventional treatment regime for breast cancer patients- an amalgamation of armamentariumDeeptashree Nandi, Dipali Sharma
Seminars in Cancer Biology|August 3, 2020
The pint- sized powerhouse: Illuminating the mighty role of the gut microbiome in improving the outcome of anti- cancer therapyIndranil Chattopadhyay, Deeptashree Nandi, Alo Nag
Gut Microbes|June 12, 2023
The gut microbiota in breast cancer development and treatment: The good, the bad, and the useful!Deeptashree Nandi, Sheetal Parida, Dipali Sharma
Cancer Metastasis Reviews|December 7, 2024
TRIM-endous functional network of tripartite motif 29 (TRIM29) in cancer progression and beyondQitong Wu, Deeptashree Nandi, Dipali Sharma
Open Biology|June 8, 2021
Exploring the therapeutic potential of forkhead box O for outfoxing COVID-19Pradeep Singh Cheema, Deeptashree Nandi, Alo Nag
Seminars in Cancer Biology|July 28, 2020
Significance of human microbiome in breast cancer: Tale of an invisible and an invincibleJatin Chadha, Deeptashree Nandi, Yama Atri, et al.
Seminars in Cancer Biology|September 1, 2017
FoxM1: Repurposing an oncogene as a biomarkerDeeptashree Nandi, Pradeep Singh Cheema, Neha Jaiswal, et al.
Carcinogenesis|June 23, 2022
The anaphase-promoting complex/cyclosome co-activator, Cdh1, is a novel target of human papillomavirus 16 E7 oncoprotein in cervical oncogenesisNeha Jaiswal, Deeptashree Nandi, Pradeep Singh Cheema, et al.
Breast Cancer Research : BCR|September 27, 2025
An enteropathogenic microbial toxin modulates the breast cancer epigenome resulting in concurrent silencing of tumor suppressor genesDeepak Verma, Deeptashree Nandi, Sheetal Parida, et al.
Frontiers in Oncology|December 13, 2021
Artemisinin Mediates Its Tumor-Suppressive Activity in Hepatocellular Carcinoma Through Targeted Inhibition of FoxM1Deeptashree Nandi, Pradeep Singh Cheema, Aakriti Singal, et al.
Pageof 2